Suprachoroidal Administration in Subjects With Metastases to the Choroid
NCT: NCT06643884 · RECRUITING
Publicidad
ID NCTNCT06643884
EstadoRECRUITING
Fecha de inicio2024-12-16
Finalización2027-10-31
SponsorAura Biosciences (INDUSTRY)
First posted
Last updated
Resumen breve
The primary objective is to assess the safety and tolerability of bel-sar treatment in subjects with metastases to the choroid from any primary solid tumor.
Fuente oficial
Ver en ClinicalTrials.gov →Datos obtenidos de la API de ClinicalTrials.gov. Para conocer el estado más reciente, consulte el registro oficial.